Cargando…

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time

BACKGROUND: Aromatase inhibitors (AIs) are recommended as adjuvant treatment for estrogen-receptor positive breast carcinoma in postmenopausal women. Studies demonstrate mixed results as to the impact of AIs on cardiovascular (CV) events and overall survival. With the increasing number of pre- and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaaban, Adnan, Petersen, Ashley, Beckwith, Heather, Florea, Natalia, Potter, David A., Yee, Douglas, Vogel, Rachel I., Duprez, Daniel, Blaes, Anne H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104271/ https://www.ncbi.nlm.nih.gov/pubmed/37066265 http://dx.doi.org/10.21203/rs.3.rs-2758909/v1

Ejemplares similares

Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
por: Blaes, Anne H., et al.
Publicado: (2023)

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment
por: Blaes, Anne, et al.
Publicado: (2015)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial
por: Wang, Haiyun, et al.
Publicado: (2023)

Cross‐sectional study of psychosocial well‐being among lesbian, gay, bisexual, and heterosexual gynecologic cancer survivors
por: Schefter, Alexandra, et al.
Publicado: (2021)

Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study
por: Blaes, Anne H, et al.
Publicado: (2018)

Sources of Medical Information for Oncology Physicians During the COVID-19 Pandemic: Results From a National Cross-Sectional Survey
por: Parsons, Helen M, et al.
Publicado: (2020)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

Perception of Telehealth During the COVID-19 Pandemic Among Survivors of Gynecologic Cancer
por: Quam, Nicholas, et al.
Publicado: (2022)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
por: Seo, Young Kyung, et al.
Publicado: (2021)

Sexually Dimorphic Effects of Aromatase on Neurobehavioral Responses
por: Shay, Dusti A., et al.
Publicado: (2018)

Endothelial Dysfunction in Childhood Cancer Survivors: A Narrative Review
por: Crocco, Marco, et al.
Publicado: (2021)

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
por: Chim, Kannie, et al.
Publicado: (2013)

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Cognitive Effects of Aromatase and Possible Role in Memory Disorders
por: Rosenfeld, Cheryl S., et al.
Publicado: (2018)

Associations between a sense of connection and existential and psychosocial outcomes in gynecologic and breast cancer survivors
por: Jewett, Patricia I., et al.
Publicado: (2022)

Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic
por: Thomaier, Lauren, et al.
Publicado: (2020)

Effect of Combining Impact-Aerobic and Strength Exercise, and Dietary Habits on Body Composition in Breast Cancer Survivors Treated with Aromatase Inhibitors
por: Garcia-Unciti, Marisol, et al.
Publicado: (2023)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Harrigan, Maura, et al.
Publicado: (2021)

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
por: Wang, Tao, et al.
Publicado: (2022)

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors
por: Fansa, Sima, et al.
Publicado: (2023)

Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery
por: Gao, Yi-Ping, et al.
Publicado: (2022)

FRI026 PPARγ Antagonists Induce Aromatase Transcription In Human Adipose Tissue Cells
por: Ardenkjær-Skinnerup, Jacob, et al.
Publicado: (2023)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Modulation of Aromatase by Phytoestrogens
por: Lephart, Edwin D.
Publicado: (2015)

Aromatase in the Human Brain
por: Azcoitia, Iñigo, et al.
Publicado: (2021)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
por: Mao, Jun J, et al.
Publicado: (2011)

Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors
por: Wagner, Monica A., et al.
Publicado: (2023)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

DVL regulation of tissue-specific aromatase transcripts in breast cancer
por: O’Hagan, Heather M.
Publicado: (2018)

Deconditioning in COVID-19 survivors with reduced exercise performance: A role for endothelial dysfunction?
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Effect of insulin resistance on CAC scores in cancer survivors
por: Jacobi, N., et al.
Publicado: (2023)

Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment
por: Wang, Shuo, et al.
Publicado: (2021)

The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature
por: Zhang, Shijia, et al.
Publicado: (2020)

Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain
por: Nyrop, Kirsten A., et al.
Publicado: (2015)

The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
por: Lu, Geling, et al.
Publicado: (2019)

Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy
por: Derzko, C., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_fdimv34ejv9q62ud307eo7sp20